nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP3A4—bone cancer	0.281	1	CbGaD
Nifedipine—ABCC3—Cisplatin—bone cancer	0.0931	0.199	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—bone cancer	0.0624	0.133	CbGbCtD
Nifedipine—ABCC3—Methotrexate—bone cancer	0.0605	0.129	CbGbCtD
Nifedipine—ABCC2—Carboplatin—bone cancer	0.0495	0.106	CbGbCtD
Nifedipine—ABCC2—Cisplatin—bone cancer	0.0423	0.0902	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—bone cancer	0.0284	0.0605	CbGbCtD
Nifedipine—ABCC2—Methotrexate—bone cancer	0.0275	0.0586	CbGbCtD
Nifedipine—CYP2B6—Cisplatin—bone cancer	0.0269	0.0574	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—bone cancer	0.018	0.0384	CbGbCtD
Nifedipine—CYP2C9—Cisplatin—bone cancer	0.0142	0.0303	CbGbCtD
Nifedipine—ABCB1—Cisplatin—bone cancer	0.0138	0.0294	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—bone cancer	0.00925	0.0197	CbGbCtD
Nifedipine—ABCB1—Methotrexate—bone cancer	0.00896	0.0191	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—bone cancer	0.00871	0.0186	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—bone cancer	0.00554	0.0118	CbGbCtD
Nifedipine—CACNA1S—pes—bone cancer	0.00553	0.459	CbGeAlD
Nifedipine—CALM1—trigeminal nerve—bone cancer	0.00133	0.111	CbGeAlD
Nifedipine—CALM1—cranial nerve—bone cancer	0.000947	0.0788	CbGeAlD
Nifedipine—Lercanidipine—CYP3A4—bone cancer	0.000572	0.136	CrCbGaD
Nifedipine—Isradipine—CYP3A4—bone cancer	0.000517	0.123	CrCbGaD
Nifedipine—Clevidipine—CYP3A4—bone cancer	0.000455	0.108	CrCbGaD
Nifedipine—Nisoldipine—CYP3A4—bone cancer	0.000436	0.104	CrCbGaD
Nifedipine—CACNA1S—tendon—bone cancer	0.000423	0.0352	CbGeAlD
Nifedipine—Nimodipine—CYP3A4—bone cancer	0.000421	0.1	CrCbGaD
Nifedipine—Nilvadipine—CYP3A4—bone cancer	0.000408	0.0971	CrCbGaD
Nifedipine—Nitrendipine—CYP3A4—bone cancer	0.000408	0.0971	CrCbGaD
Nifedipine—Amlodipine—CYP3A4—bone cancer	0.000351	0.0836	CrCbGaD
Nifedipine—KCNA1—tendon—bone cancer	0.000333	0.0277	CbGeAlD
Nifedipine—Felodipine—CYP3A4—bone cancer	0.000325	0.0773	CrCbGaD
Nifedipine—KCNA1—spinal cord—bone cancer	0.000321	0.0267	CbGeAlD
Nifedipine—Nicardipine—CYP3A4—bone cancer	0.000309	0.0736	CrCbGaD
Nifedipine—CACNA1C—connective tissue—bone cancer	0.000299	0.0248	CbGeAlD
Nifedipine—CACNB2—tendon—bone cancer	0.000254	0.0211	CbGeAlD
Nifedipine—CACNA2D1—tendon—bone cancer	0.000239	0.0199	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—bone cancer	0.000231	0.0192	CbGeAlD
Nifedipine—CALM2—connective tissue—bone cancer	0.000196	0.0163	CbGeAlD
Nifedipine—CALM1—connective tissue—bone cancer	0.000195	0.0163	CbGeAlD
Nifedipine—CALM3—tendon—bone cancer	0.000172	0.0143	CbGeAlD
Nifedipine—CALM3—bone marrow—bone cancer	0.000167	0.0138	CbGeAlD
Nifedipine—Visual impairment—Methotrexate—bone cancer	0.000166	0.00126	CcSEcCtD
Nifedipine—CALM3—spinal cord—bone cancer	0.000166	0.0138	CbGeAlD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000165	0.00125	CcSEcCtD
Nifedipine—Hypersensitivity—Cisplatin—bone cancer	0.000164	0.00125	CcSEcCtD
Nifedipine—Bradycardia—Epirubicin—bone cancer	0.000164	0.00124	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—bone cancer	0.000163	0.00123	CcSEcCtD
Nifedipine—Haemoglobin—Epirubicin—bone cancer	0.000162	0.00123	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—bone cancer	0.000162	0.00123	CcSEcCtD
Nifedipine—Rhinitis—Epirubicin—bone cancer	0.000161	0.00122	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—bone cancer	0.000161	0.00122	CcSEcCtD
Nifedipine—Haemorrhage—Epirubicin—bone cancer	0.000161	0.00122	CcSEcCtD
Nifedipine—Hepatitis—Epirubicin—bone cancer	0.000161	0.00122	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—bone cancer	0.000161	0.00122	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—bone cancer	0.00016	0.00122	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—bone cancer	0.00016	0.00122	CcSEcCtD
Nifedipine—Asthenia—Cisplatin—bone cancer	0.00016	0.00121	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—bone cancer	0.00016	0.00121	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—bone cancer	0.00016	0.00121	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—bone cancer	0.000159	0.00121	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—bone cancer	0.000159	0.00121	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—bone cancer	0.000159	0.0012	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—bone cancer	0.000158	0.0012	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—bone cancer	0.000158	0.0012	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—bone cancer	0.000158	0.0012	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000157	0.00119	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—bone cancer	0.000157	0.00119	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—bone cancer	0.000156	0.00118	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—bone cancer	0.000156	0.00118	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—bone cancer	0.000155	0.00118	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—bone cancer	0.000155	0.00118	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—bone cancer	0.000155	0.00118	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—bone cancer	0.000155	0.00118	CcSEcCtD
Nifedipine—Chills—Methotrexate—bone cancer	0.000154	0.00117	CcSEcCtD
Nifedipine—Diarrhoea—Cisplatin—bone cancer	0.000152	0.00116	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—bone cancer	0.000152	0.00116	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—bone cancer	0.000152	0.00115	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—bone cancer	0.000152	0.00115	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—bone cancer	0.000151	0.00114	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—bone cancer	0.00015	0.00114	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—bone cancer	0.00015	0.00114	CcSEcCtD
Nifedipine—Erythema—Methotrexate—bone cancer	0.00015	0.00114	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—bone cancer	0.00015	0.00114	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—bone cancer	0.00015	0.00114	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Nifedipine—Flushing—Epirubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Nifedipine—ABCC2—tendon—bone cancer	0.000149	0.0124	CbGeAlD
Nifedipine—Hepatitis—Doxorubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—bone cancer	0.000148	0.00112	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—bone cancer	0.000148	0.00112	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—bone cancer	0.000147	0.00112	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—bone cancer	0.000147	0.00111	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—bone cancer	0.000147	0.00111	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—bone cancer	0.000146	0.00111	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—bone cancer	0.000146	0.00111	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—bone cancer	0.000146	0.00111	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—bone cancer	0.000145	0.0011	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—bone cancer	0.000145	0.0011	CcSEcCtD
Nifedipine—Back pain—Methotrexate—bone cancer	0.000145	0.0011	CcSEcCtD
Nifedipine—Chills—Epirubicin—bone cancer	0.000144	0.0011	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—bone cancer	0.000144	0.00109	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—bone cancer	0.000144	0.00109	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—bone cancer	0.000142	0.00108	CcSEcCtD
Nifedipine—Vomiting—Cisplatin—bone cancer	0.000142	0.00107	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—bone cancer	0.000141	0.00107	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—bone cancer	0.000141	0.00107	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—bone cancer	0.000141	0.00107	CcSEcCtD
Nifedipine—Rash—Cisplatin—bone cancer	0.00014	0.00107	CcSEcCtD
Nifedipine—Dermatitis—Cisplatin—bone cancer	0.00014	0.00106	CcSEcCtD
Nifedipine—Erythema—Epirubicin—bone cancer	0.00014	0.00106	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—bone cancer	0.00014	0.00106	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—bone cancer	0.000139	0.00106	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—bone cancer	0.000139	0.00105	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—bone cancer	0.000139	0.00105	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—bone cancer	0.000138	0.00105	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—bone cancer	0.000138	0.00105	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—bone cancer	0.000138	0.00105	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—bone cancer	0.000138	0.00105	CcSEcCtD
Nifedipine—Tension—Epirubicin—bone cancer	0.000138	0.00104	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—bone cancer	0.000137	0.00104	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—bone cancer	0.000136	0.00103	CcSEcCtD
Nifedipine—Back pain—Epirubicin—bone cancer	0.000136	0.00103	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—bone cancer	0.000135	0.00103	CcSEcCtD
Nifedipine—Malaise—Methotrexate—bone cancer	0.000135	0.00102	CcSEcCtD
Nifedipine—CALM2—tendon—bone cancer	0.000135	0.0112	CbGeAlD
Nifedipine—Muscle spasms—Epirubicin—bone cancer	0.000135	0.00102	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—bone cancer	0.000135	0.00102	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—bone cancer	0.000135	0.00102	CcSEcCtD
Nifedipine—CALM1—tendon—bone cancer	0.000134	0.0112	CbGeAlD
Nifedipine—Mediastinal disorder—Doxorubicin—bone cancer	0.000134	0.00102	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—bone cancer	0.000134	0.00102	CcSEcCtD
Nifedipine—Chills—Doxorubicin—bone cancer	0.000134	0.00101	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—bone cancer	0.000133	0.00101	CcSEcCtD
Nifedipine—Nausea—Cisplatin—bone cancer	0.000132	0.001	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—bone cancer	0.000132	0.001	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—bone cancer	0.000132	0.000999	CcSEcCtD
Nifedipine—CALM2—bone marrow—bone cancer	0.000131	0.0109	CbGeAlD
Nifedipine—Cough—Methotrexate—bone cancer	0.000131	0.000992	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—bone cancer	0.000131	0.00099	CcSEcCtD
Nifedipine—CALM2—spinal cord—bone cancer	0.00013	0.0108	CbGeAlD
Nifedipine—CALM1—bone marrow—bone cancer	0.00013	0.0108	CbGeAlD
Nifedipine—Ill-defined disorder—Epirubicin—bone cancer	0.00013	0.000987	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—bone cancer	0.00013	0.000984	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—bone cancer	0.00013	0.000984	CcSEcCtD
Nifedipine—CALM1—spinal cord—bone cancer	0.00013	0.0108	CbGeAlD
Nifedipine—Anaemia—Epirubicin—bone cancer	0.00013	0.000983	CcSEcCtD
Nifedipine—Agitation—Epirubicin—bone cancer	0.000129	0.000977	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—bone cancer	0.000128	0.00097	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—bone cancer	0.000128	0.000968	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—bone cancer	0.000128	0.000968	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—bone cancer	0.000128	0.000968	CcSEcCtD
Nifedipine—Tension—Doxorubicin—bone cancer	0.000127	0.000966	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—bone cancer	0.000127	0.000964	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000127	0.000961	CcSEcCtD
Nifedipine—Malaise—Epirubicin—bone cancer	0.000126	0.000959	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—bone cancer	0.000126	0.000956	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—bone cancer	0.000126	0.000956	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—bone cancer	0.000126	0.000956	CcSEcCtD
Nifedipine—Syncope—Epirubicin—bone cancer	0.000126	0.000954	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—bone cancer	0.000125	0.000952	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—bone cancer	0.000125	0.000952	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—bone cancer	0.000125	0.000946	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—bone cancer	0.000124	0.00094	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—bone cancer	0.000123	0.000935	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—bone cancer	0.000123	0.000935	CcSEcCtD
Nifedipine—Cough—Epirubicin—bone cancer	0.000122	0.000928	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—bone cancer	0.000122	0.000928	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—bone cancer	0.000122	0.000927	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—bone cancer	0.00012	0.000913	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—bone cancer	0.00012	0.00091	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—bone cancer	0.00012	0.00091	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—bone cancer	0.00012	0.000908	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—bone cancer	0.000119	0.000906	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—bone cancer	0.000119	0.000906	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—bone cancer	0.000119	0.000906	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—bone cancer	0.000119	0.000904	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—bone cancer	0.000119	0.000902	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—bone cancer	0.000119	0.000901	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000119	0.000899	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—bone cancer	0.000118	0.000897	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—bone cancer	0.000118	0.000895	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—bone cancer	0.000117	0.000887	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—bone cancer	0.000117	0.000886	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—bone cancer	0.000117	0.000884	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—bone cancer	0.000117	0.000884	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—bone cancer	0.000116	0.000883	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—bone cancer	0.000116	0.000881	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—bone cancer	0.000115	0.000875	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—bone cancer	0.000115	0.00087	CcSEcCtD
Nifedipine—Oedema—Epirubicin—bone cancer	0.000114	0.000868	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—bone cancer	0.000114	0.000868	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—bone cancer	0.000114	0.000867	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—bone cancer	0.000114	0.000865	CcSEcCtD
Nifedipine—Cough—Doxorubicin—bone cancer	0.000113	0.000859	CcSEcCtD
Nifedipine—Shock—Epirubicin—bone cancer	0.000113	0.000854	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—bone cancer	0.000112	0.000851	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—bone cancer	0.000112	0.00085	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—bone cancer	0.000112	0.000847	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000111	0.000845	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—bone cancer	0.000111	0.000843	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—bone cancer	0.000111	0.000839	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—bone cancer	0.000111	0.000839	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—bone cancer	0.00011	0.000838	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—bone cancer	0.00011	0.000838	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—bone cancer	0.00011	0.000838	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—bone cancer	0.00011	0.000835	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—bone cancer	0.00011	0.000833	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00011	0.000832	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—bone cancer	0.000109	0.000828	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—bone cancer	0.000109	0.000827	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—bone cancer	0.000109	0.000827	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—bone cancer	0.000109	0.000825	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—bone cancer	0.000108	0.000819	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—bone cancer	0.000108	0.000816	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—bone cancer	0.000107	0.000811	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—bone cancer	0.000107	0.00081	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—bone cancer	0.000106	0.000806	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—bone cancer	0.000106	0.000803	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—bone cancer	0.000106	0.000803	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000106	0.000801	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—bone cancer	0.000105	0.0008	CcSEcCtD
Nifedipine—Pain—Methotrexate—bone cancer	0.000105	0.000793	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000104	0.000791	CcSEcCtD
Nifedipine—Shock—Doxorubicin—bone cancer	0.000104	0.00079	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—bone cancer	0.000104	0.000788	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—bone cancer	0.000104	0.000786	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—bone cancer	0.000103	0.000785	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—bone cancer	0.000103	0.000784	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—bone cancer	0.000103	0.00078	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—bone cancer	0.000103	0.000779	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—bone cancer	0.000102	0.000776	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—bone cancer	0.000102	0.000774	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—bone cancer	0.000102	0.000772	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—bone cancer	0.000101	0.000766	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—bone cancer	0.000101	0.000764	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—bone cancer	0.000101	0.000764	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—bone cancer	0.0001	0.000758	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—bone cancer	9.95e-05	0.000755	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—bone cancer	9.89e-05	0.000751	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—bone cancer	9.88e-05	0.000749	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—bone cancer	9.86e-05	0.000748	CcSEcCtD
Nifedipine—Pain—Epirubicin—bone cancer	9.78e-05	0.000742	CcSEcCtD
Nifedipine—Constipation—Epirubicin—bone cancer	9.78e-05	0.000742	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—bone cancer	9.71e-05	0.000737	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—bone cancer	9.66e-05	0.000733	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—bone cancer	9.66e-05	0.000733	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.64e-05	0.000732	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—bone cancer	9.57e-05	0.000726	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—bone cancer	9.51e-05	0.000721	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—bone cancer	9.44e-05	0.000716	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—bone cancer	9.43e-05	0.000715	CcSEcCtD
Nifedipine—CYP2E1—tendon—bone cancer	9.42e-05	0.00783	CbGeAlD
Nifedipine—Somnolence—Doxorubicin—bone cancer	9.41e-05	0.000714	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—bone cancer	9.36e-05	0.00071	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—bone cancer	9.32e-05	0.000707	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—bone cancer	9.2e-05	0.000698	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—bone cancer	9.14e-05	0.000693	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—bone cancer	9.13e-05	0.000692	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—bone cancer	9.09e-05	0.00069	CcSEcCtD
Nifedipine—CYP2E1—spinal cord—bone cancer	9.08e-05	0.00755	CbGeAlD
Nifedipine—Pain—Doxorubicin—bone cancer	9.05e-05	0.000687	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—bone cancer	9.05e-05	0.000687	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—bone cancer	9.04e-05	0.000686	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—bone cancer	9.04e-05	0.000686	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—bone cancer	9.01e-05	0.000683	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—bone cancer	8.77e-05	0.000666	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—bone cancer	8.72e-05	0.000662	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—bone cancer	8.66e-05	0.000657	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—bone cancer	8.65e-05	0.000656	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—bone cancer	8.43e-05	0.00064	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—bone cancer	8.41e-05	0.000638	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—bone cancer	8.37e-05	0.000635	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—bone cancer	8.37e-05	0.000635	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—bone cancer	8.36e-05	0.000635	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—bone cancer	8.21e-05	0.000623	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—bone cancer	8.09e-05	0.000614	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—bone cancer	8.08e-05	0.000613	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—bone cancer	7.83e-05	0.000594	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—bone cancer	7.8e-05	0.000592	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—bone cancer	7.77e-05	0.00059	CcSEcCtD
Nifedipine—Rash—Methotrexate—bone cancer	7.71e-05	0.000585	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—bone cancer	7.7e-05	0.000584	CcSEcCtD
Nifedipine—Headache—Methotrexate—bone cancer	7.66e-05	0.000581	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—bone cancer	7.6e-05	0.000576	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—bone cancer	7.57e-05	0.000574	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—bone cancer	7.49e-05	0.000568	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—bone cancer	7.27e-05	0.000552	CcSEcCtD
Nifedipine—Nausea—Methotrexate—bone cancer	7.26e-05	0.000551	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—bone cancer	7.24e-05	0.00055	CcSEcCtD
Nifedipine—Rash—Epirubicin—bone cancer	7.21e-05	0.000547	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—bone cancer	7.21e-05	0.000547	CcSEcCtD
Nifedipine—Headache—Epirubicin—bone cancer	7.17e-05	0.000544	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—bone cancer	7e-05	0.000531	CcSEcCtD
Nifedipine—Nausea—Epirubicin—bone cancer	6.8e-05	0.000516	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—bone cancer	6.73e-05	0.000511	CcSEcCtD
Nifedipine—Rash—Doxorubicin—bone cancer	6.67e-05	0.000506	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—bone cancer	6.67e-05	0.000506	CcSEcCtD
Nifedipine—Headache—Doxorubicin—bone cancer	6.63e-05	0.000503	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—bone cancer	6.29e-05	0.000477	CcSEcCtD
Nifedipine—ABCB1—bone marrow—bone cancer	5.2e-05	0.00432	CbGeAlD
Nifedipine—ABCB1—spinal cord—bone cancer	5.17e-05	0.0043	CbGeAlD
Nifedipine—CALM2—Signaling by FGFR in disease—EGFR—bone cancer	2.27e-05	0.000224	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	2.27e-05	0.000224	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—EGFR—bone cancer	2.27e-05	0.000224	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—MDM2—bone cancer	2.26e-05	0.000223	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—MDM2—bone cancer	2.26e-05	0.000223	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—EGFR—bone cancer	2.25e-05	0.000222	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—EGFR—bone cancer	2.25e-05	0.000222	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—SMO—bone cancer	2.23e-05	0.00022	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—EGFR—bone cancer	2.23e-05	0.00022	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—EGFR—bone cancer	2.23e-05	0.00022	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—EGFR—bone cancer	2.22e-05	0.000219	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—EGFR—bone cancer	2.22e-05	0.000219	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—EGFR—bone cancer	2.17e-05	0.000214	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—SMO—bone cancer	2.16e-05	0.000213	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—SMO—bone cancer	2.16e-05	0.000213	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RGS1—bone cancer	2.16e-05	0.000213	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—GRM4—bone cancer	2.16e-05	0.000213	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—DHFR—bone cancer	2.14e-05	0.000211	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.14e-05	0.000211	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.13e-05	0.00021	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—ENO2—bone cancer	2.12e-05	0.000209	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—PLAU—bone cancer	2.11e-05	0.000208	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—EGFR—bone cancer	2.1e-05	0.000207	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—EGFR—bone cancer	2.1e-05	0.000207	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GRM4—bone cancer	2.09e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RGS1—bone cancer	2.09e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GRM4—bone cancer	2.09e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RGS1—bone cancer	2.09e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	2.08e-05	0.000205	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—PLAU—bone cancer	2.04e-05	0.000202	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—PLAU—bone cancer	2.04e-05	0.000202	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—GNA11—bone cancer	2.04e-05	0.000201	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	2.01e-05	0.000198	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	2.01e-05	0.000198	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—GNA11—bone cancer	2e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM3—Disease—ENO2—bone cancer	1.98e-05	0.000196	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—GNA11—bone cancer	1.97e-05	0.000195	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—GNA11—bone cancer	1.97e-05	0.000195	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—DHFR—bone cancer	1.96e-05	0.000194	CbGpPWpGaD
Nifedipine—CALM2—Disease—ENO2—bone cancer	1.92e-05	0.000189	CbGpPWpGaD
Nifedipine—CALM1—Disease—ENO2—bone cancer	1.92e-05	0.000189	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—GRM1—bone cancer	1.87e-05	0.000184	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL3—bone cancer	1.85e-05	0.000182	CbGpPWpGaD
Nifedipine—CALM3—Disease—DHFR—bone cancer	1.84e-05	0.000182	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—GNA11—bone cancer	1.83e-05	0.000181	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—CYP3A4—bone cancer	1.81e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GRM1—bone cancer	1.81e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GRM1—bone cancer	1.81e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL3—bone cancer	1.79e-05	0.000176	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL3—bone cancer	1.79e-05	0.000176	CbGpPWpGaD
Nifedipine—CALM1—Disease—DHFR—bone cancer	1.78e-05	0.000176	CbGpPWpGaD
Nifedipine—CALM2—Disease—DHFR—bone cancer	1.78e-05	0.000176	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.77e-05	0.000175	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ATF1—bone cancer	1.73e-05	0.000171	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—ENO2—bone cancer	1.71e-05	0.000168	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—KIT—bone cancer	1.69e-05	0.000167	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL3—bone cancer	1.69e-05	0.000167	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ATF1—bone cancer	1.68e-05	0.000165	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ATF1—bone cancer	1.68e-05	0.000165	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ENO2—bone cancer	1.67e-05	0.000165	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.67e-05	0.000165	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ENO2—bone cancer	1.67e-05	0.000165	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000164	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ENO2—bone cancer	1.66e-05	0.000164	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KIT—bone cancer	1.64e-05	0.000162	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KIT—bone cancer	1.64e-05	0.000162	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL3—bone cancer	1.63e-05	0.000161	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL3—bone cancer	1.63e-05	0.000161	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KIT—bone cancer	1.62e-05	0.00016	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ENO2—bone cancer	1.61e-05	0.000159	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ENO2—bone cancer	1.61e-05	0.000159	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—EGFR—bone cancer	1.6e-05	0.000158	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—DHFR—bone cancer	1.58e-05	0.000156	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—PTGS2—bone cancer	1.58e-05	0.000156	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ENO2—bone cancer	1.58e-05	0.000156	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KIT—bone cancer	1.57e-05	0.000155	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KIT—bone cancer	1.57e-05	0.000155	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—GSTP1—bone cancer	1.55e-05	0.000153	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—DHFR—bone cancer	1.55e-05	0.000153	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—DHFR—bone cancer	1.55e-05	0.000153	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—EGFR—bone cancer	1.54e-05	0.000152	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—EGFR—bone cancer	1.54e-05	0.000152	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—DHFR—bone cancer	1.54e-05	0.000152	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—PTGS2—bone cancer	1.49e-05	0.000147	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—DHFR—bone cancer	1.49e-05	0.000147	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—DHFR—bone cancer	1.49e-05	0.000147	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—GNA11—bone cancer	1.48e-05	0.000146	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—DHFR—bone cancer	1.46e-05	0.000144	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—GNA11—bone cancer	1.45e-05	0.000143	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—GNA11—bone cancer	1.45e-05	0.000143	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ENO2—bone cancer	1.45e-05	0.000143	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—GNA11—bone cancer	1.44e-05	0.000142	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—GSTP1—bone cancer	1.42e-05	0.00014	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.4e-05	0.000138	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—GNA11—bone cancer	1.39e-05	0.000137	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—GNA11—bone cancer	1.39e-05	0.000137	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—GNA11—bone cancer	1.37e-05	0.000135	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.34e-05	0.000132	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—DHFR—bone cancer	1.34e-05	0.000132	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFBR2—bone cancer	1.33e-05	0.000132	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—MDM2—bone cancer	1.33e-05	0.000131	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SMO—bone cancer	1.32e-05	0.00013	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CYP3A4—bone cancer	1.31e-05	0.00013	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PTGS2—bone cancer	1.31e-05	0.00013	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.31e-05	0.000129	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CYP3A4—bone cancer	1.31e-05	0.000129	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFBR2—bone cancer	1.29e-05	0.000127	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFBR2—bone cancer	1.29e-05	0.000127	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—MDM2—bone cancer	1.29e-05	0.000127	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—MDM2—bone cancer	1.29e-05	0.000127	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—MDM2—bone cancer	1.28e-05	0.000126	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SMO—bone cancer	1.27e-05	0.000126	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SMO—bone cancer	1.27e-05	0.000126	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CYP3A4—bone cancer	1.26e-05	0.000125	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CYP3A4—bone cancer	1.26e-05	0.000125	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ENO2—bone cancer	1.26e-05	0.000124	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—GNA11—bone cancer	1.25e-05	0.000124	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CYP3A4—bone cancer	1.24e-05	0.000122	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—MDM2—bone cancer	1.24e-05	0.000122	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—MDM2—bone cancer	1.24e-05	0.000122	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.23e-05	0.000122	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—GNA11—bone cancer	1.2e-05	0.000119	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ENO2—bone cancer	1.19e-05	0.000117	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PTGS2—bone cancer	1.18e-05	0.000116	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ENO2—bone cancer	1.18e-05	0.000116	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—DHFR—bone cancer	1.17e-05	0.000115	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—GNA11—bone cancer	1.17e-05	0.000115	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—GNA11—bone cancer	1.17e-05	0.000115	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—JUN—bone cancer	1.16e-05	0.000114	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—GSTP1—bone cancer	1.15e-05	0.000113	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.14e-05	0.000112	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.13e-05	0.000112	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—GSTP1—bone cancer	1.12e-05	0.000111	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—GSTP1—bone cancer	1.12e-05	0.000111	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—JUN—bone cancer	1.12e-05	0.000111	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—JUN—bone cancer	1.12e-05	0.000111	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ATF1—bone cancer	1.12e-05	0.00011	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—GSTP1—bone cancer	1.12e-05	0.00011	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—DHFR—bone cancer	1.1e-05	0.000109	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL3—bone cancer	1.09e-05	0.000108	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—GNA11—bone cancer	1.09e-05	0.000108	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—DHFR—bone cancer	1.09e-05	0.000108	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ATF1—bone cancer	1.08e-05	0.000107	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ATF1—bone cancer	1.08e-05	0.000107	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—GSTP1—bone cancer	1.08e-05	0.000107	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—GSTP1—bone cancer	1.08e-05	0.000107	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—GSTP1—bone cancer	1.06e-05	0.000105	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL3—bone cancer	1.06e-05	0.000104	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL3—bone cancer	1.06e-05	0.000104	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GNA11—bone cancer	1.03e-05	0.000101	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GNA11—bone cancer	1.02e-05	0.000101	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ENO2—bone cancer	1.01e-05	9.92e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CYP3A4—bone cancer	9.9e-06	9.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KIT—bone cancer	9.86e-06	9.72e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—GSTP1—bone cancer	9.72e-06	9.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KIT—bone cancer	9.53e-06	9.41e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KIT—bone cancer	9.53e-06	9.41e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFBR2—bone cancer	9.34e-06	9.21e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP3A4—bone cancer	9.33e-06	9.2e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—DHFR—bone cancer	9.32e-06	9.2e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP3A4—bone cancer	9.25e-06	9.12e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.2e-06	9.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—EGFR—bone cancer	9.11e-06	8.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KIT—bone cancer	9.1e-06	8.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFBR2—bone cancer	9.03e-06	8.91e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFBR2—bone cancer	9.03e-06	8.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—EGFR—bone cancer	8.81e-06	8.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—EGFR—bone cancer	8.81e-06	8.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KIT—bone cancer	8.8e-06	8.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KIT—bone cancer	8.8e-06	8.69e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF1R—bone cancer	8.79e-06	8.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—EGFR—bone cancer	8.75e-06	8.63e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GNA11—bone cancer	8.71e-06	8.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—BRAF—bone cancer	8.55e-06	8.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1R—bone cancer	8.5e-06	8.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1R—bone cancer	8.5e-06	8.39e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—bone cancer	8.49e-06	8.38e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—GSTP1—bone cancer	8.46e-06	8.35e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—EGFR—bone cancer	8.46e-06	8.35e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—EGFR—bone cancer	8.46e-06	8.35e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—BRAF—bone cancer	8.27e-06	8.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—BRAF—bone cancer	8.27e-06	8.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—bone cancer	8.22e-06	8.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—bone cancer	8.22e-06	8.11e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTGS2—bone cancer	8.04e-06	7.93e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GSTP1—bone cancer	7.98e-06	7.87e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GSTP1—bone cancer	7.91e-06	7.8e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP3A4—bone cancer	7.9e-06	7.8e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.86e-06	7.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MDM2—bone cancer	7.76e-06	7.66e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ENO2—bone cancer	7.76e-06	7.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MDM2—bone cancer	7.51e-06	7.41e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MDM2—bone cancer	7.51e-06	7.41e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—bone cancer	7.37e-06	7.27e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—DHFR—bone cancer	7.2e-06	7.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MDM2—bone cancer	7.17e-06	7.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MDM2—bone cancer	6.93e-06	6.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MDM2—bone cancer	6.93e-06	6.84e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—bone cancer	6.91e-06	6.82e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTP1—bone cancer	6.76e-06	6.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—JUN—bone cancer	6.75e-06	6.66e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GNA11—bone cancer	6.73e-06	6.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—bone cancer	6.68e-06	6.59e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—bone cancer	6.68e-06	6.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—JUN—bone cancer	6.53e-06	6.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—JUN—bone cancer	6.53e-06	6.44e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KIT—bone cancer	6.37e-06	6.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KIT—bone cancer	6.16e-06	6.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KIT—bone cancer	6.16e-06	6.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—BRAF—bone cancer	5.99e-06	5.91e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—bone cancer	5.95e-06	5.87e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—bone cancer	5.82e-06	5.75e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—bone cancer	5.81e-06	5.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—bone cancer	5.81e-06	5.73e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—BRAF—bone cancer	5.79e-06	5.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—BRAF—bone cancer	5.79e-06	5.72e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—bone cancer	5.79e-06	5.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—bone cancer	5.62e-06	5.54e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—bone cancer	5.62e-06	5.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—bone cancer	5.6e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—bone cancer	5.6e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—bone cancer	5.49e-06	5.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—bone cancer	5.3e-06	5.23e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—bone cancer	5.21e-06	5.15e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—bone cancer	5.13e-06	5.06e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—bone cancer	5.13e-06	5.06e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—bone cancer	5.03e-06	4.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—bone cancer	5.02e-06	4.95e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—bone cancer	4.9e-06	4.83e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—bone cancer	4.85e-06	4.79e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—bone cancer	4.85e-06	4.79e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—bone cancer	4.74e-06	4.67e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—bone cancer	4.74e-06	4.67e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—bone cancer	4.38e-06	4.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—bone cancer	4.36e-06	4.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—bone cancer	4.24e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—bone cancer	4.22e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—bone cancer	4.22e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—bone cancer	4.13e-06	4.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—bone cancer	4.11e-06	4.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—bone cancer	4.11e-06	4.05e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—bone cancer	4.1e-06	4.04e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—bone cancer	3.5e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—bone cancer	3.43e-06	3.38e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—bone cancer	3.32e-06	3.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—bone cancer	3.32e-06	3.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—bone cancer	2.88e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—bone cancer	2.79e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—bone cancer	2.79e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—bone cancer	2.7e-06	2.67e-05	CbGpPWpGaD
